JPH09118624A - 真性糖尿病の経口処置用タングステン（ｖｉ）組成物 - Google Patents

真性糖尿病の経口処置用タングステン（ｖｉ）組成物

Info

Publication number
JPH09118624A
JPH09118624A JP19733096A JP19733096A JPH09118624A JP H09118624 A JPH09118624 A JP H09118624A JP 19733096 A JP19733096 A JP 19733096A JP 19733096 A JP19733096 A JP 19733096A JP H09118624 A JPH09118624 A JP H09118624A
Authority
JP
Japan
Prior art keywords
tungsten
tungstate
compound
insulin
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP19733096A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09118624A5 (enExample
Inventor
Cirera Joan Josep Guinovart
ホアン・ホセ・ジョノバルト・シレラ
Lluis Albert Barbera
アルベルト・バルベラ・ルイス
Gil Joan Enric Rodriguez
ホアン・エンリク・ロドリゲス・ヒル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Bayer Hispania SL
Original Assignee
Bayer Pharma AG
Quimica Farmaceutica Bayer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG, Quimica Farmaceutica Bayer SA filed Critical Bayer Pharma AG
Publication of JPH09118624A publication Critical patent/JPH09118624A/ja
Publication of JPH09118624A5 publication Critical patent/JPH09118624A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP19733096A 1995-07-26 1996-07-26 真性糖尿病の経口処置用タングステン（ｖｉ）組成物 Pending JPH09118624A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9501603A ES2108642B1 (es) 1995-07-26 1995-07-26 Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
ES9501603 1995-07-26

Publications (2)

Publication Number Publication Date
JPH09118624A true JPH09118624A (ja) 1997-05-06
JPH09118624A5 JPH09118624A5 (enExample) 2004-08-12

Family

ID=8291317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19733096A Pending JPH09118624A (ja) 1995-07-26 1996-07-26 真性糖尿病の経口処置用タングステン（ｖｉ）組成物

Country Status (2)

Country Link
JP (1) JPH09118624A (enExample)
ES (1) ES2108642B1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009502891A (ja) * 2005-07-29 2009-01-29 ユニベルシダード デ バルセロナ 神経変性疾患、特にアルツハイマー病及び統合失調症の治療のためのタングステン酸塩（ｖｉ）を含有してなる製薬的組成物
JP2016505057A (ja) * 2013-01-22 2016-02-18 オキソライフ エセ．エレ． 非糖尿病の哺乳動物における雌性不妊症の治療のためのタングステン（ｖｉ）塩の使用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2187276B1 (es) 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
CN100515428C (zh) * 2007-04-26 2009-07-22 暨南大学 钨酸锂在制药中的应用
ES2478696B1 (es) * 2012-12-21 2015-05-06 Universitat De Barcelona Sales de tungstato como agentes antiplaquetarios
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)
EP3173382B1 (en) * 2014-07-21 2023-01-04 Oxolife, S.L. Tungsten (vi) salts for stimulating fertility and reproduction and for improving the effectiveness of assisted reproduction techniques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025928A (ja) * 1983-07-21 1985-02-08 Tanaka Seinosuke 薬剤
JPS6025916A (ja) * 1983-07-21 1985-02-08 Tanaka Seinosuke 入浴水

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009502891A (ja) * 2005-07-29 2009-01-29 ユニベルシダード デ バルセロナ 神経変性疾患、特にアルツハイマー病及び統合失調症の治療のためのタングステン酸塩（ｖｉ）を含有してなる製薬的組成物
JP2016505057A (ja) * 2013-01-22 2016-02-18 オキソライフ エセ．エレ． 非糖尿病の哺乳動物における雌性不妊症の治療のためのタングステン（ｖｉ）塩の使用

Also Published As

Publication number Publication date
ES2108642B1 (es) 1998-08-16
ES2108642A1 (es) 1997-12-16

Similar Documents

Publication Publication Date Title
Boden et al. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non—insulin-dependent diabetes mellitus
US9795578B2 (en) Enterically coated cysteamine, cystamine and derivatives thereof
US4673691A (en) Human weight loss inducing method
US20110118180A1 (en) Method of treatment of diabetes type 2 comprising add-on therapy to metformin
US6291495B1 (en) Method and composition for the treatment of diabetes
JP2024038042A (ja) 肥満の治療および体重管理のためのｇｌｐ－１組成物
TW503107B (en) Composition for treatment of insulin resistance syndromes
Abukurah et al. Acute sodium fluoride poisoning
US5712259A (en) NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
EP0755681A1 (en) Tungsten (VI) compositions for the oral treatment of diabetes mellitus
Mathu et al. A study of Biguanides in the Care of Type II DIABETES mellitus
US20040224031A1 (en) Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus
US4565830A (en) Method of ameliorating the subjective symptoms and objective signs in congestive heart failure
EP1338280A1 (en) Combination of amines and vanadium (iv)/(v) compounds for the treatment and/or prevention of diabetes mellitus
WO1999016432A1 (en) A drug for treating diabetic nephrosis
EP1156795A1 (en) Use of succinic acid or salts thereof and method of treating insulin resistance
JPH08245403A (ja) インシュリン抵抗性症候群治療用組成物
Heikinheimo Severe prolonged hypoglycemia following tolbutamide and carbutamide treatment
CA2685636C (en) Method of treatment of diabetes type 2 comprising add-on therapy to metformin
AU2013267044B2 (en) Enterically coated cysteamine, cystamine and derivatives thereof
Benyo et al. Vacor Intoxication—Chemical Diabetes Extraordinary
HK40031827A (en) Enterically coated cysteamine and salts thereof
Agent et al. ENTUZITY™ KwikPen®

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070227

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070528

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070821